Profiling the Impact of Medium Formulation on Morphology and Functionality of Primary Hepatocytes in vitro

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Nelson, Leonard J ^a   Treskes, Philipp ^a   Howie, A Forbes ^a   Walker, Simon W ^a   Hayes, Peter C ^a   Plevris, John N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GALACTOSE; SERUM ALBUMIN; UREA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL ORGANELLE; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; LIVER CELL; METABOLISM; REPRODUCIBILITY; SWINE; ULTRASTRUCTURE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; CYTOCHROME P-450 ENZYME SYSTEM; GALACTOSE; HEPATOCYTES; HUMANS; ORGANELLES; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; SWINE; UREA;

EID: 84884952411     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02735     Document Type: Article

References (60)

1. Jasmund, I. et al. The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes. Biomol. Eng. 24, 59-69 (2007).
2. Carpentier, B., Gautier, A. & Legallais, C. Artificial and bioartificial liver devices: present and future. Gut 58, 1690-1702 (2009).
3. Ekser, B. et al. Clinical xenotransplantation: the next medical revolution? Lancet 379, 672-683 (2012).
4. Laine, J. E., Auriola, S., Pasanen, M. & Juvonen, R. O. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica. (2009).
5. Puccinelli, E., Gervasi, P. G. & Longo, V. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Curr. Drug. Metab. 12, 507-525 (2011).
6. Maringka, M., Giri, S., Nieber, K., Acikgo?z, A. & Bader, A. Biotransformation of diazepam in a clinically relevant flat membrane bioreactor model using primary porcine hepatocytes. Fundam. Clin. Pharmacol. 25, 343-353 (2011).
7. Frankish, H. Pig organ transplantation brought one step closer. Lancet 359, 137 (2002).
8. Pless, G. in Hepatocytes. 511-523 (Humana Press, 2010).
9. Poyck, P. P. C. et al. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Int. J. Artif. Organs. 30, 183-191 (2007).
10. Fiegel, H. C. et al. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J. Cell. Mol. Med. 12, 56-66 (2008).
11. Lang, R. et al. Three-dimensional culture of hepatocytes on porcine liver tissuederived extracellular matrix. Biomaterials 32, 7042-7052 (2011).
12. Denner, J. & Tonjes, R. R. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin. Microbiol. Rev. 25, 318-343 (2012).
13. Tsiaoussis, J., Newsome, P. N., Nelson, L. J., Hayes, P. C. & Plevris, J. N. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl. 7, 2-10 (2001).
14. Nelson, L. J. et al. An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems. Eur. J. Gastroenterol. Hepatol. 12, 923-930 (2000).
15. Newsome, P. N., Plevris, J. N., Nelson, L. J. & Hayes, P. C. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl. 6, 21-31 (2000).
16. Skaanild,M. T. Porcine cytochrome P450 and metabolism. Curr. Pharm. Des. 12, 1421-1427 (2006).
17. Desille, M. et al. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 68, 1437-1443 (1999).
18. Donato, M. T., Castell, J. V. & Gómez-Lechón, M. J. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J. Hepatol. 31, 542-549 (1999).
19. Gregory, P. G., Connolly, C. K., Toner, M. and Sullivan, S. J. In vitro characterization of porcine hepatocyte function. Cell Transplant 9, 1-10 (2000).
20. Naik, S., Trenkler, D., Santangini, H., Pan, J. & Jauregui, H. O. Isolation and culture of porcine hepatocytes for artificial liver support. Cell Transplant. 5, 107-115 (1996).
21. LeCluyse, E. L., Bullock, P. L. & Parkinson, A. Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes. Adv. Drug. Deliv. Rev. 22, 133-186 (1996).
22. Nelson, L. J., Walker, S. W., Hayes, P. C. & Plevris, J. N. Low-shear modelled microgravity environment maintains morphology and differentiated functionality of primary porcine hepatocyte cultures. Cells Tissues Organs 192, 125-140 (2010).
23. Barrila, J. et al. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat. Rev. Microbiol. 8, 791-801 (2010).
24. Mitaka, T. The current status of primary hepatocyte culture. Int. J. Exp. Pathol. 79, 393-409 (2002).
25. Demetriou, A. & Rozga, J. in Liver Growth and Repair. 627-652 (Springer, Netherlands, 1998).
26. Berry, M., Grivell, A., Grivell, M. & Phillips, J. Isolated hepatocytes-past, present and future. Cell. Biol. Toxicol. 13, 223-233 (1997).
27. Enat, R. et al. Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 81, 1411-1415 (1984).
28. te Velde, A. A., Ladiges, N. C. J. J., Flendrig, L. M. & Chamuleau, R. A. F. M. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver. J. Hepatol. 23, 184-192 (1995).
29. LeCluyse, E., Bullock, P., Madan, A., Carroll, K. & Parkinson, A. Influence of Extracellular Matrix Overlay and Medium Formulation on the Induction of Cytochrome P-450 2B Enzymes in Primary Cultures of Rat Hepatocytes. Drug. Metab. Dispos. 27, 909-915 (1999).
30. Watts, P. et al. The influence of medium composition on the maintenance of cytochrome P-450, glutathione content and urea synthesis: a comparison of rat and sheep primary hepatocyte cultures. J. Hepatol. 23, 605-612 (1995).
31. Schneider, C., Aurich, H., Wenkel, R. & Christ, B. Propagation and functional characterization of serum-free cultured porcine hepatocytes for downstream applications. Cell Tissue Res. 323, 433-442 (2006).
32. Flendrig, L. M. et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J. Hepatol. 26, 1379-1392 (1997).
33. De Bartolo, L., Jarosch-Von Schweder, G., Haverich, A. & Bader, A. A novel fullscale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol. Progr. 16, 102-108 (2000).
34. Gerlach, J., Klo?ppel, K., Stoll, P., Vienken, J. & Mu?ller, C. Gas supply across membranes in bioreactors for hepatocyte culture. Int. J. Artif. Organs. 14, 328-333 (1990).
35. Kong, L. B., Chen, S., Demetriou, A. A. & Rozga, J. Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use. Int. J. Artif. Organs. 19, 72-78 (1996).
36. Hamilton, G., Fox, R., Atterwill, C. & Gedorge, E. Liver spheroids as a long term model for liver toxicity in vitro. Hum. Exp. Toxicol. 15, 153 (1995).
37. Lazar, A. et al. Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant. 4, 259-268 (1995).
38. Olsen, A. K.,Hansen, K. T. and Friis, C. Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alpha-ethynylestradiol. Chem. Biol. Interact. 107, 93-108 (1997).
39. Dong, J. et al. Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology. Cytotechnology 57, 251-261 (2008).
40. Wang, L. et al. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant. 7, 459-468 (1998).
41. Maringka, M., Giri, S. & Bader, A. Preclinical characterization of primary porcine hepatocytes in a clinically relevant flat membrane bioreactor. Biomaterials 31, 156-172 (2010).
42. Nyberg, S. L. et al. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant. 2, 441-452 (1993).
43. Sielaff, T. D. et al. A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation 59, 1459-1463 (1995).
44. Yu, Y. et al. Cell therapies for liver diseases. Liver Transpl. 18, 9-21 (2012).
45. Nibourg, G. A. et al. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PLoS One 7, e38778 (2012).
46. Kano, J., Tokiwa, T., Zhou, X. & Kodama, M. Colonial growth and differentiation of epithelial cells derived from abattoir adult porcine livers. J. Gastroenterol. Hepatol. 13 Suppl, S62-69 (1998).
47. Ampola, M. in The Liver, Biology and Pathobiology. 365-377 (Raven Press, New York, 1994).
48. Fox, I. J. & Roy-Chowdhury, J. Hepatocyte transplantation. J. Hepatol. 40, 878-886 (2004).
49. Yamamoto, T. et al. Treatment of acute liver failure in mice by hepatocyte xenotransplantation. Cell Transplant. 19, 799-806 (2010).
50. Kaplowitz, N. Liver and biliary diseases. (Williams & Wilkins, 1992).
51. Iwata, H. et al. In vitro evaluation of metabolic functions of a bioartificial liver. ASAIO J. 45, 299-306 (1999).
52. Blei, A. T. Medical therapy of brain edema in fulminant hepatic failure. Hepatology 32, 666-669 (2000).
53. Jauregui, H. O. & Gann, K. L. Mammalian hepatocytes as a foundation for treatment in human liver failure. J. Cell. Biochem. 45, 359-365 (1991).
54. Monshouwer, M., van't Klooster, G. A. E., Nijmeijer, S. M.,Witkamp, R. F. & van Miert, A. S. J. P. A. M. Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol. In Vitro 12, 715-723 (1998).
55. Chesne, C. et al. Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation. Hepatology 18, 406-414 (1993).
56. Padgham, C. R. & Paine, A. J. Altered expression of cytochrome P-450 mRNAs, and potentially of other transcripts encoding key hepatic functions, are triggered during the isolation of rat hepatocytes. Biochem. J. 289 (Pt 3), 621-624 (1993).
57. Lubberstedt, M. et al. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drugmetabolism assessment in vitro. J Pharmacol. Toxicol. Methods 63, 59-68 (2011).
58. Sielaff, T. D. et al. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J. Surg. Res. 59, 179-184 (1995).
59. Newsome, P. N. et al. Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure. BMC Gastroenterol. 10, 34 (2010).
60. Kessler, M. A., Meinitzer, A. & Wolfbeis, O. S. Albumin blue 580 fluorescence assay for albumin. Anal. Biochem. 248, 180-182 (1997).